Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease

Free Radical Biology and Medicine

Volumn 62, Issue , 2013, Pages 90-101

  Yana, Michael H ^a   Wang, Xinglong ^a,b   Zhu, Xiongwei ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; DNA; Free radicals; Mitochondrial; Mitochondrial dynamics; Mitochondrial dysfunction; Oxidative stress; Parkinson disease

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; NEUROTOXIN; PARKIN; REACTIVE OXYGEN METABOLITE; TRANSFER RNA;

ALZHEIMER DISEASE; BRAIN MITOCHONDRION; DELETION MUTANT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DJ-1 MUTANT (DROSOPHILA); GENE MUTATION; GENE OVEREXPRESSION; HELA CELL; HERITABILITY; HOMEOSTASIS; HUMAN; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOPHAGY; MOLECULAR PATHOLOGY; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARKINSON DISEASE; PINK1 MUTANT (DROSOPHILA); PRIORITY JOURNAL; REVIEW;

EID: 84884879594     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.11.014     Document Type: Review

References (202)

1. Liochev, S. I.; Fridovich, I. The role of O2- in the production of HO": in vitro and in vivo. Free Radic. Biol. Med. 16: 29-33; 1994.
2. Parihar, M. S.; Brewer, G.J. Mitoenergetic failure in Alzheimer disease. Am.J. Physiol. Cell Physiol 292:C8-23; 2007.
3. Hollenbeck, P. J.; Saxton, W. M. The axonal transport of mitochondria. J. Cell Sci. 118: 5411-5419; 2005. (Pubitemid 43079283)
4. Lebel, M.; Picard, F.; Ferland, G.; Gaudreau, P. Drugs, nutrients, and phytoactive principles improving the health span of rodent models of human age-related diseases. J. Gerontol. A Biol. Sci. Med. Sci 67: 140-151; 2012.
5. Lu, T.; Pan, Y.; Kao, S. Y.; Li, C; Kohane, I.; Chan, J.; Yankner, B. A. Gene regulation and DNA damage in the ageing human brain. Nature 429: 883-891; 2004. (Pubitemid 38843301)
6. Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E. K.; Jones, P. K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S.; Atwood, C. S.; Petersen, R. B.; Smith, M. A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60: 759-767; 2001. (Pubitemid 32678256)
7. Chinta, S. J.; Andersen, J. K. Redox imbalance in Parkinson's disease. Biochim. Biophys. Acta 1362-1367: 2008; 1780.
8. Schon, E. A.; Przedborski, S. Mitochondria: the next (neurode)generation. Neuron 70: 1033-1053; 2011.
9. Zhu, X.; Castellani, R. J.; Moreira, P. I.; Aliev, G.; Shenk, J. C; Siedlak, S. L.; Harris, P. L.; Fujioka, H.; Sayre, L. M.; Szweda, P. A.; Szweda, L I.; Smith, M. A.; Perry, G. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radic. Biol. Med. 52: 699-704; 2012.
10. Swerdlow, R. H. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence Antioxid. Redox Signaling 16: 950-964; 2012.
11. Crider, D. G.; Garcia-Rodriguez, L J.; Srivastava, P.; Peraza-Reyes, L.; Upadhyaya, K.; Boldogh, I. R.; Pon, L. A. Rad53 is essential for a mitochondrial DNA inheritance checkpoint regulating G1 to S progression. J. Cell Biol. 198: 793-798; 2012.
12. Wallace, D. C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256: 628-632; 1992.
13. Wang, D.; Kreutzer, D. A.; Essigmann, J. M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res. 400: 99-115; 1998. (Pubitemid 28440215)
14. De Bont, R.; van Larebeke, N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 19: 169-185; 2004. (Pubitemid 38744825)
15. Bohr, V. A. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic. Biol. Med 32: 804-812; 2002. (Pubitemid 34439251)
16. Christmann, M.; Tomicic, M. T.; Roos, W. P.; Kaina, B. Mechanisms of human DNA repair: an update. Toxicology 193: 3-34; 2003. (Pubitemid 37340141)
17. Yen, T. C; Su, J. H.; King, K. L; Wei, Y. H. Ageing-associated 5 kb deletion in human liver mitochondrial DNA. Biochem. Biophys. Res. Commun. 178: 124-131; 1991.
18. Lee, H. C; Pang, C. Y.; Hsu, H. S.; Wei, Y. H. Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human ageing. Biochim. Biophys. Acta 1226: 37-43; 1994.
19. Hsieh, R. H.; Hou, J. H.; Hsu, H. S.; Wei, Y. H. Age-dependent respiratory function decline and DNA deletions in human muscle mitochondria. Biochem. Mol. Biol. Int. 32: 1009-1022; 1994.
20. Lezza, A. M.; Boffoli, D.; Scacco, S.; Cantatore, P.; Gadaleta, M. N. Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles. Biochem. Biophys. Res. Commun. 205: 772-779; 1994.
21. Piccolo, G.; Banfi, P.; Azan, G.; Rizzuto, R.; Bisson, R.; Sandona, D.; Bellomo, G. Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia. J. Neurol. Sci. 105: 57-60; 1991.
22. Smits, P.; Mattijssen, S.; Morava, E.; van den Brand, M.; van den Brandt, F.; Wijburg, F.; Pruijn, G.; Smeitink, J.; Nijtmans, L.; Rodenburg, R.; van den Heuvel, L. Functional consequences of mitochondrial tRNA Trp and tRNA Arg mutations causing combined OXPHOS defects. Eur. J. Hum. Genet. 18: 324-329.
23. Mahata, B.; Mukherjee, S.; Mishra, S.; Bandyopadhyay, A.; Adhya, S. Functional delivery of a cytosolic tRNA into mutant mitochondria of human cells. Science 314: 471-474; 2006. (Pubitemid 44628969)
24. Masucci, J. P.; Schon, E. A.; King, M. P. Point mutations in the mitochondrial tRNA(Lys) gene: implications for pathogenesis and mechanism. Mol. Cell. Biochem. 174: 215-219; 1997.
25. Danielson, S. R.; Wong, A.; Carelli, V.; Martinuzzi, A.; Schapira, A. H.; Cortopassi, G. A. Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-induced apoptosis. J. Biol. Chem. 277: 5810-5815; 2002. (Pubitemid 34968359)
26. Liu, C. Y.; Lee, C. F.; Wei, Y. H. Activation of PKCdelta and ERK1/2 in the sensitivity to UV-induced apoptosis of human cells harboring 4977 bp deletion of mitochondrial DNA. Biochim. Biophys. Acta 783-790: 2009; 1792.
27. Wu, S. B.; Ma, Y. S.; Wu, Y. T.; Chen, Y. C.; Wei, Y. H. Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome. Mol. Neurobiol. 41: 256-266; 2010.
28. Ikawa, M.; Arakawa, K.; Hamano, T.; Nagata, M.; Nakamoto, Y.; Kuriyama, M.; Koga, Y.; Yoneda, M. Evaluation of systemic redox states in patients carrying the MELAS A3243G mutation in mitochondrial DNA. Eur. Neurol. 67: 232-237; 2012.
29. Wong, A.; Cavelier, L.; Collins-Schramm, H. E.; Seldin, M. F.; McGrogan, M.; Savontaus, M. L.; Cortopassi, G. A. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum. Mol. Genet 11: 431-438; 2002. (Pubitemid 34213616)
30. Trifunovic, A.; Hansson, A.; Wredenberg, A.; Rovio, A. T.; Dufour, E.; Khvorostov, I.; Spelbrink, J. N.; Wibom, R.; Jacobs, H. T.; Larsson, N. G. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc. Natl. Acad. Sci. USA 102: 17993-17998; 2005. (Pubitemid 41798490)
31. Kujoth, G. C.; Hiona, A.; Pugh, T. D.; Someya, S.; Panzer, K.; Wohlgemuth, S. E.; Hofer, T.; Seo, A. Y.; Sullivan, R.; Jobling, W. A.; Morrow, J. D.; Van Remmen, H.; Sedivy, J. M.; Yamasoba, T.; Tanokura, M.; Weindruch, R.; Leeuwenburgh, C.; Prolla, T. A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481-484; 2005. (Pubitemid 40994689)
32. Ahlqvist, K. J.; Hamalainen, R. H.; Yatsuga, S.; Uutela, M.; Terzioglu, M.; Gotz, A.; Forsstrom, S.; Salven, P.; Angers-Loustau, A.; Kopra, O. H.; Tyynismaa, H.; Larsson, N. G.; Wartiovaara, K.; Prolla, T.; Trifunovic, A.; Suomalainen, A. Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab. 15: 100-109; 2012.
33. Dai, D. F.; Chen, T.; Wanagat, J.; Laflamme, M.; Marcinek, D. J.; Emond, M. J.; Ngo, C. P.; Prolla, T. A.; Rabinovitch, P. S. Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 9: 536-544; 2010.
34. Chan, D. C. Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 22: 79-99; 2006.
35. Chen, H.; McCaffery, J. M.; Chan, D. C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130: 548-562; 2007. (Pubitemid 47198302)
36. Chan, D. C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 125: 1241-1252; 2006. (Pubitemid 43929096)
37. Knott, A. B.; Perkins, G.; Schwarzenbacher, R.; Bossy-Wetzel, E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9: 505-518; 2008. (Pubitemid 351873464)
38. Su, B.; Wang, X.; Zheng, L.; Perry, G.; Smith, M. A.; Zhu, X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim. Biophys. Acta 135-142: 2010; 1802.
39. Chen, H.; Chomyn, A.; Chan, D. C. Disruption of fusion results in mitochon-drial heterogeneity and dysfunction. J. Biol. Chem. 280: 26185-26192; 2005. (Pubitemid 41022214)
40. Ishihara, N.; Eura, Y.; Mihara, K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J. Cell Sci 117: 6535-6546; 2004. (Pubitemid 40214575)
41. Cipolat, S.; Martins de Brito, O.; Dal Zilio, B.; Scorrano, L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. USA 101: 15927-15932; 2004. (Pubitemid 39507904)
42. Twig, G.; Elorza, A.; Molina, A. J.; Mohamed, H.; Wikstrom, J. D.; Walzer, G.; Stiles, L.; Haigh, S. E.; Katz, S.; Las, G.; Alroy, J.; Wu, M.; Py, B. F.; Yuan, J.; Deeney, J. T.; Corkey, B. E.; Shirihai, O. S. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27: 433-446; 2008. (Pubitemid 351161653)
43. James, D. I.; Parone, P. A.; Mattenberger, Y.; Martinou, J. C. hFis1, a novel component of the mammalian mitochondrial fission machinery. J. Biol. Chem. 278: 36373-36379; 2003. (Pubitemid 37139965)
44. Taguchi, N.; Ishihara, N.; Jofuku, A.; Oka, T.; Mihara, K. Mitotic phosphor-ylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282: 11521-11529; 2007. (Pubitemid 47100787)
45. Cribbs, J. T.; Strack, S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 8: 939-944; 2007. (Pubitemid 47500477)
46. Cho, D. H.; Nakamura, T.; Fang, J.; Cieplak, P.; Godzik, A.; Gu, Z.; Lipton, S. A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324: 102-105; 2009.
47. Harder, Z.; Zunino, R.; McBride, H. Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr. Biol. 14: 340-345; 2004. (Pubitemid 38300214)
48. Nakamura, N.; Kimura, Y.; Tokuda, M.; Honda, S.; Hirose, S. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep. 7: 1019-1022; 2006. (Pubitemid 44480517)
49. Otera, H.; Wang, C.; Cleland, M. M.; Setoguchi, K.; Yokota, S.; Youle, R. J.; Mihara, K. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 191: 1141-1158; 2010.
50. Zhao, J.; Liu, T.; Jin, S.; Wang, X.; Qu, M.; Uhlen, P.; Tomilin, N.; Shupliakov, O.; Lendahl, U.; Nister, M. Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. EMBO J. 30: 2762-2778; 2011.
51. Jendrach, M.; Mai, S.; Pohl, S.; Voth, M.; Bereiter-Hahn, J. Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion 8: 293-304; 2008.
52. Cereghetti, G. M.; Stangherlin, A.; Martins de Brito, O.; Chang, C. R.; Blackstone, C.; Bernardi, P.; Scorrano, L. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl. Acad. Sci. USA 105: 15803-15808; 2008.
53. Han, X. J.; Lu, Y. F.; Li, S. A.; Kaitsuka, T.; Sato, Y.; Tomizawa, K.; Nairn, A. C.; Takei, K.; Matsui, H.; Matsushita, M. CaM kinase I alpha-induced phos-phorylation of Drp1 regulates mitochondrial morphology. J. Cell Biol. 182: 573-585; 2008.
54. Chen, H.; Detmer, S. A.; Ewald, A. J.; Griffin, E. E.; Fraser, S. E.; Chan, D. C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160: 189-200; 2003. (Pubitemid 36254953)
55. Benard, G.; Bellance, N.; James, D.; Parrone, P.; Fernandez, H.; Letellier, T.; Rossignol, R. Mitochondrial bioenergetics and structural network organization. J. Cell Sci. 120: 838-848; 2007. (Pubitemid 46523485)
56. Frieden, M.; James, D.; Castelbou, C.; Danckaert, A.; Martinou, J. C.; Demaurex, N. Ca2+ homeostasis during mitochondrial fragmentation and perinuclear clustering induced by hFis1. J. Biol. Chem. 279: 22704-22714; 2004. (Pubitemid 38679471)
57. Szabadkai, G.; Simoni, A. M.; Chami, M.; Wieckowski, M. R.; Youle, R. J.; Rizzuto, R. Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis. Mol. Cell 16: 59-68; 2004. (Pubitemid 39330152)
58. Frank, S.; Gaume, B.; Bergmann-Leitner, E. S.; Leitner, W. W.; Robert, E. G.; Catez, F.; Smith, C. L.; Youle, R. J. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1: 515-525; 2001. (Pubitemid 33586103)
59. Frezza, C.; Cipolat, S.; Martins de Brito, O.; Mii, M.; Beznoussenko, G. V.; Rudka, T.; Bartoli, D.; Polishuck, R. S.; Danial, N. N.; De Strooper, B.; Scorrano, L. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126: 177-189; 2006.
60. Cipolat, S.; Rudka, T.; Hartmann, D.; Costa, V.; Serneels, L.; Craessaerts, K.; Metzger, K.; Frezza, C.; Annaert, W.; D'Adamio, L.; Derks, C.; Dejaegere, T.; Pellegrini, L.; D'Hooge, R.; Scorrano, L.; De Strooper, B. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126: 163-175; 2006.
61. Sugioka, R.; Shimizu, S.; Tsujimoto, Y. Fzo1, a protein involved in mitochon-drial fusion, inhibits apoptosis. J. Biol. Chem. 279: 52726-52734; 2004. (Pubitemid 39656648)
62. Olichon, A.; Baricault, L.; Gas, N.; Guillou, E.; Valette, A.; Belenguer, P.; Lenaers, G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 278: 7743-7746; 2003. (Pubitemid 36800505)
63. Yu, T.; Robotham, J. L.; Yoon, Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochon-drial morphology. Proc. Natl. Acad. Sci. USA 103: 2653-2658; 2006.
64. Darshi, M.; Mendiola, V. L.; Mackey, M. R.; Murphy, A. N.; Koller, A.; Perkins, G. A.; Ellisman, M. H.; Taylor, S. S. ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mito-chondrial function. J. Biol. Chem. 286: 2918-2932; 2011.
65. Liu, W.; Acin-Perez, R.; Geghman, K. D.; Manfredi, G.; Lu, B.; Li, C. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc. Natl. Acad. Sci. USA 108: 12920-12924; 2011.
66. Mita, S.; Schmidt, B.; Schon, E. A.; DiMauro, S.; Bonilla, E. Detection of ''deleted'' mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc. Natl. Acad. Sci. USA 86: 9509-9513; 1989. (Pubitemid 20010456)
67. Shadel, G. S.; Clayton, D. A. Mitochondrial DNA maintenance in vertebrates. Annu. Rev. Biochem. 66: 409-435; 1997.
68. Corral-Debrinski, M.; Horton, T.; Lott, M. T.; Shoffner, J. M.; McKee, A. C.; Beal, M. F.; Graham, B. H.; Wallace, D. C. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23: 471-476; 1994. (Pubitemid 24308270)
69. Hirai, K.; Aliev, G.; Nunomura, A.; Fujioka, H.; Russell, R. L.; Atwood, C. S.; Johnson, A. B.; Kress, Y.; Vinters, H. V.; Tabaton, M.; Shimohama, S.; Cash, A. D.; Siedlak, S. L.; Harris, P. L.; Jones, P. K.; Petersen, R. B.; Perry, G.; Smith, M. A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21: 3017-3023; 2001. (Pubitemid 32323483)
70. Arbuzova, S.; Hutchin, T.; Cuckle, H. Mitochondrial dysfunction and Down's syndrome. Bioessays 24: 681-684; 2002. (Pubitemid 34850322)
71. Coskun, P. E.; Beal, M. F.; Wallace, D. C. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl. Acad. Sci. USA 101: 10726-10731; 2004. (Pubitemid 38955810)
72. Mecocci, P.; MacGarvey, U.; Beal, M. F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36: 747-751; 1994. (Pubitemid 24337634)
73. Coskun, P.; Wyrembak, J.; Schriner, S. E.; Chen, H. W.; Marciniack, C.; Laferla, F.; Wallace, D. C. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 553-564: 2012; 1820.
74. Coskun, P. E.; Wyrembak, J.; Derbereva, O.; Melkonian, G.; Doran, E.; Lott, I. T.; Head, E.; Cotman, C. W.; Wallace, D. C. Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and Down syndrome dementia. J. Alzheimers Dis. 20(Suppl. 2):S293-310; 2010.
75. Shoffner, J. M.; Brown, M. D.; Torroni, A.; Lott, M. T.; Cabell, M. F.; Mirra, S. S.; Beal, M. F.; Yang, C. C.; Gearing, M.; Salvo, R., et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184; 1993. (Pubitemid 23205074)
76. Hutchin, T.; Cortopassi, G. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc. Natl. Acad. Sci. USA 92: 6892-6895; 1995.
77. van der Walt, J. M.; Dementieva, Y. A.; Martin, E. R.; Scott, W. K.; Nicodemus, K. K.; Kroner, C. C.; Welsh-Bohmer, K. A.; Saunders, A. M.; Roses, A. D.; Small, G. W.; Schmechel, D. E.; Murali Doraiswamy, P.; Gilbert, J. R.; Haines, J. L.; Vance, J. M.; Pericak-Vance, M. A. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci. Lett. 365: 28-32; 2004. (Pubitemid 38952729)
78. Lakatos, A.; Derbeneva, O.; Younes, D.; Keator, D.; Bakken, T.; Lvova, M.; Brandon, M.; Guffanti, G.; Reglodi, D.; Saykin, A.; Weiner, M.; Macciardi, F.; Schork, N.; Wallace, D. C.; Potkin, S. G. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol. Aging 31: 1355-1363; 2010.
79. Carrieri, G.; Bonafe, M.; De Luca, M.; Rose, G.; Varcasia, O.; Bruni, A.; Maletta, R.; Nacmias, B.; Sorbi, S.; Corsonello, F.; Feraco, E.; Andreev, K. F.; Yashin, A. I.; Franceschi, C.; De Benedictis, G. Mitochondrial DNA hap-logroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum. Genet. 108: 194-198; 2001. (Pubitemid 32293664)
80. Strittmatter, W. J.; Weisgraber, K. H.; Huang, D. Y.; Dong, L. M.; Salvesen, G. S.; Pericak-Vance, M.; Schmechel, D.; Saunders, A. M.; Goldgaber, D.; Roses, A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102; 1993. (Pubitemid 23260862)
81. Guerreiro, R. J.; Gustafson, D. R.; Hardy, J. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol. Aging 33: 437-456; 2012.
82. Lee, C. Y.; Tse, W.; Smith, J. D.; Landreth, G. E. Apolipoprotein E promotes b-amyloid trafficking and degradation by modulating microglial cholesterol levels. J. Biol. Chem. 287: 2032-2044; 2012.
83. Chagnon, P.; Gee, M.; Filion, M.; Robitaille, Y.; Belouchi, M.; Gauvreau, D. Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am. J. Med. Genet. 85: 20-30; 1999. (Pubitemid 29256801)
84. Honea, R. A.; Swerdlow, R. H.; Vidoni, E. D.; Goodwin, J.; Burns, J. M. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 74: 113-120; 2010.
85. Hudson, G.; Sims, R.; Harold, D.; Chapman, J.; Hollingworth, P.; Gerrish, A.; Russo, G.; Hamshere, M.; Moskvina, V.; Jones, N.; Thomas, C.; Stretton, A.; Holmans, P. A.; O'Donovan, M. C.; Owen, M. J.; Williams, J.; Chinnery, P. F. No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 78: 1038-1042; 2012.
86. Elson, J. L.; Herrnstadt, C.; Preston, G.; Thal, L.; Morris, C. M.; Edwardson, J. A.; Beal, M. F.; Turnbull, D. M.; Howell, N. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum. Genet. 119: 241-254; 2006.
87. Khan, S. M.; Cassarino, D. S.; Abramova, N. N.; Keeney, P. M.; Borland, M. K.; Trimmer, P. A.; Krebs, C. T.; Bennett, J. C.; Parks, J. K.; Swerdlow, R. H.; Parker Jr W. D.; Bennett Jr. J. P. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann. Neurol. 48: 148-155; 2000. (Pubitemid 30617032)
88. Sheehan, J. P.; Swerdlow, R. H.; Parker, W. D.; Miller, S. W.; Davis, R. E.; Tuttle, J. B. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J. Neurochem. 68: 1221-1233; 1997. (Pubitemid 27086228)
89. Scheffler, K.; Krohn, M.; Dunkelmann, T.; Stenzel, J.; Miroux, B.; Ibrahim, S.; von Bohlen, Und; Halbach, O.; Heinze, H. J.; Walker, L. C.; Gsponer, J. A.; Pahnke, J. Mitochondrial DNA polymorphisms specifically modify cerebral b-amyloid proteostasis. Acta Neuropathol. 124: 199-208; 2012.
90. Wang, X.; Su, B.; Lee, H. G.; Li, X.; Perry, G.; Smith, M. A.; Zhu, X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 29: 9090-9103; 2009.
91. Bossy, B.; Petrilli, A.; Klinglmayr, E.; Chen, J.; Lutz-Meindl, U.; Knott, A. B.; Masliah, E.; Schwarzenbacher, R.; Bossy-Wetzel, E. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J. Alzheimers Dis. 20(Suppl. 2):S513-526; 2010.
92. Manczak, M.; Calkins, M. J.; Reddy, P. H. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum. Mol. Genet 20: 2495-2509; 2011.
93. Manczak, M.; Reddy, P. H. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet 21: 2538-2547; 2012.
94. Wang, X.; Su, B.; Fujioka, H.; Zhu, X. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am. J. Pathol 173: 470-482; 2008.
95. Wang, S.; Song, J.; Tan, M.; Albers, K. M.; Jia, J. Mitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer's disease. Eur. J. Neurol. 19: 1015-1022; 2012.
96. Wang, X.; Su, B.; Siedlak, S. L.; Moreira, P. I.; Fujioka, H.; Wang, Y.; Casadesus, G.; Zhu, X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. USA 105: 19318-19323; 2008.
97. Calkins, M. J.; Manczak, M.; Mao, P.; Shirendeb, U.; Reddy, P. H. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum. Mol. Genet 20: 4515-4529; 2011.
98. Trushina, E.; Nemutlu, E.; Zhang, S.; Christensen, T.; Camp, J.; Mesa, J.; Siddiqui, A.; Tamura, Y.; Sesaki, H.; Wengenack, T. M.; Dzeja, P. P.; Poduslo, J. F. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One 7:e32737; 2012.
99. Zhao, X. L.; Wang, W. A.; Tan, J. X.; Huang, J. K.; Zhang, X.; Zhang, B. Z.; Wang, Y. H.; YangCheng, H. Y.; Zhu, H. L.; Sun, X. J.; Huang, F. D. Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. J. Neurosci. 30: 1512-1522; 2010.
100. Iijima-Ando, K.; Hearn, S. A.; Shenton, C.; Gatt, A.; Zhao, L.; Iijima, K. Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One 4:e8310; 2009.
101. Shahpasand, K.; Uemura, I.; Saito, T.; Asano, T.; Hata, K.; Shibata, K.; Toyoshima, Y.; Hasegawa, M.; Hisanaga, S. Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J. Neurosci. 32: 2430-2441; 2012.
102. Rissman, R. A.; Poon, W. W.; Blurton-Jones, M.; Oddo, S.; Torp, R.; Vitek, M. P.; LaFerla, F. M.; Rohn, T. T.; Cotman, C. W. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114: 121-130; 2004. (Pubitemid 39071651)
103. Cho, M. H.; Kim, D. H.; Choi, J. E.; Chang, E. J.; Seung, Y. Increased phosphorylation of dynamin-related protein 1 and mitochondrial fission in okadaic acid-treated neurons. Brain Res. 1454: 100-110; 2012.
104. Quintanilla, R. A.; Matthews-Roberson, T. A.; Dolan, P. J.; Johnson, G. V. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. J. Biol. Chem. 284: 18754-18766; 2009.
105. Quintanilla, R. A.; Dolan, P. J.; Jin, Y. N.; Johnson, G. V. Truncated tau and Abeta cooperatively impair mitochondria in primary neurons. Neurobiol. Aging 33(619):e625-e635; 2012.
106. Duboff, B.; Gotz, J.; Feany, M. B. Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 75: 618-632; 2012.
107. De Vos, K. J.; Allan, V. J.; Grierson, A. J.; Sheetz, M. P. Mitochondrial function and actin regulate dynamin-related protein 1-dependent mitochondrial fission. Curr. Biol. 15: 678-683; 2005.
108. Autere, J.; Moilanen, J. S.; Finnila, S.; Soininen, H.; Mannermaa, A.; Hartikainen, P.; Hallikainen, M.; Majamaa, K. Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia. Hum. Genet. 115: 29-35; 2004. (Pubitemid 38787215)
109. Ross, O. A.; McCormack, R.; Maxwell, L. D.; Duguid, R. A.; Quinn, D. J.; Barnett, Y. A.; Rea, I. M.; El-Agnaf, O. M.; Gibson, J. M.; Wallace, A.; Middleton, D.; Curran, M. D. mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish. Exp. Gerontol. 38: 397-405; 2003. (Pubitemid 36379075)
110. van der Walt, J. M.; Nicodemus, K. K.; Martin, E. R.; Scott, W. K.; Nance, M. A.; Watts, R. L.; Hubble, J. P.; Haines, J. L.; Koller, W. C.; Lyons, K.; Pahwa, R.; Stern, M. B.; Colcher, A.; Hiner, B. C.; Jankovic, J.; Ondo, W. G.; Allen Jr F. H.; Goetz, C. G.; Small, G. W.; Mastaglia, F.; Stajich, J. M.; McLaurin, A. C.; Middleton, L. T.; Scott, B. L.; Schmechel, D. E.; Pericak-Vance, M. A.; Vance, J. M. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72: 804-811; 2003. (Pubitemid 36403301)
111. Pyle, A.; Foltynie, T.; Tiangyou, W.; Lambert, C.; Keers, S. M.; Allcock, L. M.; Davison, J.; Lewis, S. J.; Perry, R. H.; Barker, R.; Burn, D. J.; Chinnery, P. F. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann. Neurol. 57: 564-567; 2005. (Pubitemid 40471169)
112. Bender, A.; Krishnan, K. J.; Morris, C. M.; Taylor, G. A.; Reeve, A. K.; Perry, R. H.; Jaros, E.; Hersheson, J. S.; Betts, J.; Klopstock, T.; Taylor, R. W.; Turnbull, D. M. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38: 515-517; 2006.
113. Kraytsberg, Y.; Kudryavtseva, E.; McKee, A. C.; Geula, C.; Kowall, N. W.; Khrapko, K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38: 518-520; 2006.
114. Smigrodzki, R.; Parks, J.; Parker, W. D. High frequency of mitochondrial complex I mutations in Parkinson's disease and aging. Neurobiol. Aging 25: 1273-1281; 2004. (Pubitemid 39299163)
115. Pickrell, A. M.; Pinto, M.; Hida, A.; Moraes, C. T. Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease. J. Neurosci. 31: 17649-17658; 2011.
116. Davidzon, G.; Greene, P.; Mancuso, M.; Klos, K. J.; Ahlskog, J. E.; Hirano, M.; DiMauro, S. Early-onset familial parkinsonism due to POLG mutations. Ann. Neurol. 59: 859-862; 2006. (Pubitemid 43673164)
117. Hudson, G.; Schaefer, A. M.; Taylor, R. W.; Tiangyou, W.; Gibson, A.; Venables, G.; Griffiths, P.; Burn, D. J.; Turnbull, D. M.; Chinnery, P. F. Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism. Arch. Neurol. 64: 553-557; 2007. (Pubitemid 46588345)
118. Luoma, P.; Melberg, A.; Rinne, J. O.; Kaukonen, J. A.; Nupponen, N. N.; Chalmers, R. M.; Oldfors, A.; Rautakorpi, I.; Peltonen, L.; Majamaa, K.; Somer, H.; Suomalainen, A. Parkinsonism, premature menopause, and mitochon-drial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364: 875-882; 2004. (Pubitemid 39221065)
119. Luoma, P. T.; Eerola, J.; Ahola, S.; Hakonen, A. H.; Hellstrom, O.; Kivisto, K. T.; Tienari, P. J.; Suomalainen, A. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology 69: 1152-1159; 2007. (Pubitemid 47517561)
120. Ghezzi, D.; Marelli, C.; Achilli, A.; Goldwurm, S.; Pezzoli, G.; Barone, P.; Pellecchia, M. T.; Stanzione, P.; Brusa, L.; Bentivoglio, A. R.; Bonuccelli, U.; Petrozzi, L.; Abbruzzese, G.; Marchese, R.; Cortelli, P.; Grimaldi, D.; Marti-nelli, P.; Ferrarese, C.; Garavaglia, B.; Sangiorgi, S.; Carelli, V.; Torroni, A.; Albanese, A.; Zeviani, M. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur. J. Hum. Genet. 13: 748-752; 2005. (Pubitemid 40846847)
121. Simon, D. K.; Lin, M. T.; Zheng, L.; Liu, G. J.; Ahn, C. H.; Kim, L. M.; Mauck, W. M.; Twu, F.; Beal, M. F.; Johns, D. R. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol. Aging 25: 71-81; 2004. (Pubitemid 37522195)
122. Lin, M. T.; Cantuti-Castelvetri, I.; Zheng, K.; Jackson, K. E.; Tan, Y. B.; Arzberger, T.; Lees, A. J.; Betensky, R. A.; Beal, M. F.; Simon, D. K. Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann. Neurol. 71: 850-854; 2012.
123. Tan, E. K.; Skipper, L. M. Pathogenic mutations in Parkinson disease. Hum. Mutat. 28: 641-653; 2007. (Pubitemid 47047290)
124. Lesage, S.; Brice, A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet 18:R48-59; 2009.
125. Gegg, M. E.; Cooper, J. M.; Schapira, A. H.; Taanman, J. W. Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells. PLoS One 4:e4756; 2009.
126. Hatcher, J. M.; Pennell, K. D.; Miller, G. W. Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol. Sci. 29: 322-329; 2008.
127. Bonifati, V.; Rizzu, P.; van Baren, M. J.; Schaap, O.; Breedveld, G. J.; Krieger, E.; Dekker, M. C.; Squitieri, F.; Ibanez, P.; Joosse, M.; van Dongen, J. W.; Vanacore, N.; van Swieten, J. C.; Brice, A.; Meco, G.; van Duijn, C. M.; Oostra, B. A.; Heutink, P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259; 2003. (Pubitemid 36131051)
128. Engelender, S.; Kaminsky, Z.; Guo, X.; Sharp, A. H.; Amaravi, R. K.; Kleiderlein, J. J.; Margolis, R. L.; Troncoso, J. C.; Lanahan, A. A.; Worley, P. F.; Dawson, V. L.; Dawson, T. M.; Ross, C. A. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet. 22: 110-114; 1999. (Pubitemid 29214817)
129. Kitada, T.; Asakawa, S.; Hattori, N.; Matsumine, H.; Yamamura, Y.; Minoshima, S.; Yokochi, M.; Mizuno, Y.; Shimizu, N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608; 1998. (Pubitemid 28207717)
130. Matsumine, H.; Saito, M.; Shimoda-Matsubayashi, S.; Tanaka, H.; Ishikawa, A.; Nakagawa-Hattori, Y.; Yokochi, M.; Kobayashi, T.; Igarashi, S.; Takano, H.; Sanpei, K.; Koike, R.; Mori, H.; Kondo, T.; Mizutani, Y.; Schaffer, A. A.; Yamamura, Y.; Nakamura, S.; Kuzuhara, S.; Tsuji, S.; Mizuno, Y. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am. J. Hum. Genet. 60: 588-596; 1997. (Pubitemid 27097607)
131. Paisan-Ruiz, C.; Jain, S.; Evans, E. W.; Gilks, W. P.; Simon, J.; van der Brug, M.; Lopez de Munain, A.; Aparicio, S.; Gil, A. M.; Khan, N.; Johnson, J.; Martinez, J. R.; Nicholl, D.; Carrera, I. M.; Pena, A. S.; de Silva, R.; Lees, A.; Marti-Masso, J. F.; Perez-Tur, J.; Wood, N. W.; Singleton, A. B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600; 2004. (Pubitemid 39531224)
132. Polymeropoulos, M. H.; Lavedan, C.; Leroy, E.; Ide, S. E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E. S.; Chandrase-kharappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W. G.; Lazzarini, A. M.; Duvoisin, R. C.; Di Iorio, G.; Golbe, L. I.; Nussbaum, R. L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047; 1997. (Pubitemid 27443610)
133. Spillantini, M. G.; Schmidt, M. L.; Lee, V. M.; Trojanowski, J. Q.; Jakes, R.; Goedert, M. Alpha-synuclein in Lewy bodies. Nature 388: 839-840; 1997.
134. Valente, E. M.; Abou-Sleiman, P. M.; Caputo, V.; Muqit, M. M.; Harvey, K.; Gispert, S.; Ali, Z.; Del Turco, D.; Bentivoglio, A. R.; Healy, D. G.; Albanese, A.; Nussbaum, R.; Gonzalez-Maldonado, R.; Deller, T.; Salvi, S.; Cortelli, P.; Gilks, W. P.; Latchman, D. S.; Harvey, R. J.; Dallapiccola, B.; Auburger, G.; Wood, N. W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160; 2004. (Pubitemid 38661852)
135. Zimprich, A.; Biskup, S.; Leitner, P.; Lichtner, P.; Farrer, M.; Lincoln, S.; Kachergus, J.; Hulihan, M.; Uitti, R. J.; Calne, D. B.; Stoessl, A. J.; Pfeiffer, R. F.; Patenge, D. W.; Carbajal, I. C.; Vieregge, P.; Asmus, F.; Muller-Myhsok, B.; Dickson, D. W.; Meitinger, T.; Strom, T. M.; Wszolek, Z. K.; Gasser, T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleo-morphic pathology. Neuron 44: 601-607; 2004. (Pubitemid 39531225)
136. Henchcliffe, C.; Beal, M. F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 4: 600-609; 2008.
137. Przedborski, S.; Vila, M. The 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann. N. Y. Acad. Sci. 991: 189-198; 2003. (Pubitemid 36793814)
138. Przedborski, S.; Jackson-Lewis, V.; Djaldetti, R.; Liberatore, G.; Vila, M.; Vukosavic, S.; Almer, G. The parkinsonian toxin MPTP: action and mechanism. Restor. Neurol. Neurosci. 16: 135-142; 2000. (Pubitemid 30159159)
139. Choi, W. S.; Kruse, S. E.; Palmiter, R. D.; Xia, Z. Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc. Natl. Acad. Sci. USA 105: 15136-15141; 2008.
140. Wang, X.; Su, B.; Liu, W.; He, X.; Gao, Y.; Castellani, R. J.; Perry, G.; Smith, M. A.; Zhu, X. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease. Aging Cell 10: 807-823; 2011.
141. Barsoum, M. J.; Yuan, H.; Gerencser, A. A.; Liot, G.; Kushnareva, Y.; Graber, S.; Kovacs, I.; Lee, W. D.; Waggoner, J.; Cui, J.; White, A. D.; Bossy, B.; Martinou, J. C.; Youle, R. J.; Lipton, S. A.; Ellisman, M. H.; Perkins, G. A.; Bossy-Wetzel, E. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 25: 3900-3911; 2006. (Pubitemid 44300275)
142. Gomez-Lazaro, M.; Bonekamp, N. A.; Galindo, M. F.; Jordan, J.; Schrader, M. 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells. Free Radic. Biol. Med. 44: 1960-1969; 2008.
143. Song, D. D.; Shults, C. W.; Sisk, A.; Rockenstein, E.; Masliah, E. Enhanced substantia nigra mitochondrial pathology in human a-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186: 158-172; 2004. (Pubitemid 38333191)
144. Martin, L. J.; Pan, Y.; Price, A. C.; Sterling, W.; Copeland, N. G.; Jenkins, N. A.; Price, D. L.; Lee, M. K. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26: 41-50; 2006. (Pubitemid 43089519)
145. Lin, M. T.; Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795; 2006. (Pubitemid 44622683)
146. Chinta, S. J.; Mallajosyula, J. K.; Rane, A.; Andersen, J. K. Mitochondrial a-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci. Lett. 486: 235-239; 2010.
147. Liu, G.; Zhang, C.; Yin, J.; Li, X.; Cheng, F.; Li, Y.; Yang, H.; Ueda, K.; Chan, P.; Yu, S. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci. Lett. 454: 187-192; 2009.
148. Kamp, F.; Exner, N.; Lutz, A. K.; Wender, N.; Hegermann, J.; Brunner, B.; Nuscher, B.; Bartels, T.; Giese, A.; Beyer, K.; Eimer, S.; Winklhofer, K. F.; Haass, C. Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J. 29: 3571-3589; 2010.
149. Nakamura, K.; Nemani, V. M.; Azarbal, F.; Skibinski, G.; Levy, J. M.; Egami, K.; Munishkina, L.; Zhang, J.; Gardner, B.; Wakabayashi, J.; Sesaki, H.; Cheng, Y.; Finkbeiner, S.; Nussbaum, R. L.; Masliah, E.; Edwards, R. H. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J. Biol. Chem. 286: 20710-20726; 2011.
150. Xie, W.; Chung, K. K. Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease. J. Neurochem 122: 404-414; 2012.
151. Zhou, C.; Huang, Y.; Shao, Y.; May, J.; Prou, D.; Perier, C.; Dauer, W.; Schon, E. A.; Przedborski, S. The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc. Natl. Acad. Sci. USA 105: 12022-12027; 2008.
152. Kim, Y.; Park, J.; Kim, S.; Song, S.; Kwon, S. K.; Lee, S. H.; Kitada, T.; Kim, J. M.; Chung, J. PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem. Biophys. Res. Commun. 377: 975-980; 2008.
153. Clark, I. E.; Dodson, M. W.; Jiang, C.; Cao, J. H.; Huh, J. R.; Seol, J. H.; Yoo, S. J.; Hay, B. A.; Guo, M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441: 1162-1166; 2006. (Pubitemid 43990738)
154. Manczak, M.; Anekonda, T. S.; Henson, E.; Park, B. S.; Quinn, J.; Reddy, P. H. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet 15: 1437-1449; 2006.
155. Yang, Y.; Gehrke, S.; Imai, Y.; Huang, Z.; Ouyang, Y.; Wang, J. W.; Yang, L.; Beal, M. F.; Vogel, H.; Lu, B. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. USA 103: 10793-10798; 2006. (Pubitemid 44078055)
156. Deng, H.; Dodson, M. W.; Huang, H.; Guo, M. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. USA 105: 14503-14508; 2008.
157. Poole, A. C.; Thomas, R. E.; Andrews, L. A.; McBride, H. M.; Whitworth, A. J.; Pallanck, L. J. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. USA 105: 1638-1643; 2008. (Pubitemid 351346567)
158. Park, J.; Lee, G.; Chung, J. The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem. Biophys. Res. Commun. 378: 518-523; 2009.
159. Yang, Y.; Ouyang, Y.; Yang, L.; Beal, M. F.; McQuibban, A.; Vogel, H.; Lu, B. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc. Natl. Acad. Sci. USA 105: 7070-7075; 2008. (Pubitemid 351754531)
160. Mortiboys, H.; Thomas, K. J.; Koopman, W. J.; Klaffke, S.; Abou-Sleiman, P.; Olpin, S.; Wood, N. W.; Willems, P. H.; Smeitink, J. A.; Cookson, M. R.; Bandmann, O. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann. Neurol. 64: 555-565; 2008.
161. Lutz, A. K.; Exner, N.; Fett, M. E.; Schlehe, J. S.; Kloos, K.; Laemmermann, K.; Brunner, B.; Kurz-Drexler, A.; Vogel, F.; Reichert, A. S.; Bouman, L.; Vogt-Weisenhorn, D.; Wurst, W.; Tatzelt, J.; Haass, C.; Winklhofer, K. F. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J. Biol. Chem. 284: 22938-22951; 2009.
162. Exner, N.; Treske, B.; Paquet, D.; Holmstrom, K.; Schiesling, C.; Gispert, S.; Carballo-Carbajal, I.; Berg, D.; Hoepken, H. H.; Gasser, T.; Kruger, R.; Winklhofer, K. F.; Vogel, F.; Reichert, A. S.; Auburger, G.; Kahle, P. J.; Schmid, B.; Haass, C. Loss-of-function of human PINK1 results in mitochon-drial pathology and can be rescued by parkin. J. Neurosci. 27: 12413-12418; 2007. (Pubitemid 350085485)
163. Sandebring, A.; Thomas, K. J.; Beilina, A.; van der Brug, M.; Cleland, M. M.; Ahmad, R.; Miller, D. W.; Zambrano, I.; Cowburn, R. F.; Behbahani, H.; Cedazo-Minguez, A.; Cookson, M. R. Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS One 4:e5701; 2009.
164. Grunewald, A.; Gegg, M. E.; Taanman, J. W.; King, R. H.; Kock, N.; Klein, C.; Schapira, A. H. Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Exp. Neurol. 219(1): 266-273; 2009.
165. Wang, H.; Song, P.; Du, L.; Tian, W.; Yue, W.; Liu, M.; Li, D.; Wang, B.; Zhu, Y.; Cao, C.; Zhou, J.; Chen, Q. Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J. Biol. Chem. 286: 11649-11658; 2011.
166. Meissner, C.; Lorenz, H.; Weihofen, A.; Selkoe, D. J.; Lemberg, M. K. The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J. Neurochem. 117: 856-867; 2011.
167. Jin, S. M.; Lazarou, M.; Wang, C.; Kane, L. A.; Narendra, D. P.; Youle, R. J. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191: 933-942; 2010.
168. Jin, S. M.; Youle, R. J. PINK1- and Parkin-mediated mitophagy at a glance. J. Cell Sci. 125: 795-799; 2012.
169. Siddiqui, A.; Hanson, I.; Andersen, J. K. Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin. Free Radic. Res. 46: 1011-1018; 2012.
170. Kuroda, Y.; Mitsui, T.; Kunishige, M.; Shono, M.; Akaike, M.; Azuma, H.; Matsumoto, T. Parkin enhances mitochondrial biogenesis in proliferating cells. Hum. Mol. Genet 15: 883-895; 2006. (Pubitemid 43338230)
171. Shin, J. H.; Ko, H. S.; Kang, H.; Lee, Y.; Lee, Y. I.; Pletinkova, O.; Troconso, J. C.; Dawson, V. L.; Dawson, T. M. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 144: 689-702; 2011.
172. Bonifati, V.; Rizzu, P.; van Baren, M. J.; Schaap, O.; Breedveld, G. J.; Krieger, E.; Dekker, M. C. J.; Squitieri, F.; Ibanez, P.; Joosse, M.; van Dongen, J. W.; Vanacore, N.; van Swieten, J. C.; Brice, A.; Meco, G.; van Duijn, C. M.; Oostra, B. A.; Heutink, P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259; 2003. (Pubitemid 36131051)
173. Bandyopadhyay, S.; Cookson, M. R. Evolutionary and functional relationships within the DJ1 superfamily. BMC Evol. Biol. 4; 2004.
174. Lucas, J. I.; Marin, I. A new evolutionary paradigm for the Parkinson disease gene DJ-1. Mol. Biol. Evol. 24: 551-561; 2007. (Pubitemid 46204387)
175. Cookson, M. R. D. J. -1. PINK1, and their effects on mitochondrial pathways. Mov. Disord 25:S44-S48; 2010.
176. Taira, T.; Saito, Y.; Niki, T.; Iguchi-Ariga, S. M.; Takahashi, K.; Ariga, H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5: 213-218; 2004. (Pubitemid 38401204)
177. Clements, C. M.; McNally, R. S.; Conti, B. J.; Mak, T. W.; Ting, J. P. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antiox-idant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. USA 103: 15091-15096; 2006. (Pubitemid 44583169)
178. Goldberg, M. S.; Pisani, A.; Haburcak, M.; Vortherms, T. A.; Kitada, T.; Costa, C.; Tong, Y.; Martella, G.; Tscherter, A.; Martins, A.; Bernardi, G.; Roth, B. L.; Pothos, E. N.; Calabresi, P.; Shen, J. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45: 489-496; 2005. (Pubitemid 40249861)
179. Kim, R. H.; Smith, P. D.; Aleyasin, H.; Hayley, S.; Mount, M. P.; Pownall, S.; Wakeham, A.; You-Ten, A. J.; Kalia, S. K.; Horne, P.; Westaway, D.; Lozano, A. M.; Anisman, H.; Park, D. S.; Mak, T. W. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxida-tive stress. Proc. Natl. Acad. Sci. USA 102: 5215-5220; 2005.
180. Paterna, J. C.; Leng, A.; Weber, E.; Feldon, J.; Bueler, H. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol. Ther. 15: 698-704; 2007. (Pubitemid 46431989)
181. Canet-Aviles, R. M.; Wilson, M. A.; Miller, D. W.; Ahmad, R.; McLendon, C.; Bandyopadhyay, S.; Baptista, M. J.; Ringe, D.; Petsko, G. A.; Cookson, M. R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. USA 101: 9103-9108; 2004. (Pubitemid 38781618)
182. Junn, E.; Jang, W. H.; Zhao, X.; Jeong, B. S.; Mouradian, M. M. Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J. Neurosci. Res. 87: 123-129; 2009.
183. Irrcher, I.; Aleyasin, H.; Seifert, E.L.; Hewitt, S.J.; Chhabra, S.; Phillips, M.; Lutz, A.K.; Rousseaux, M.W.; Bevilacqua, L.; Jahani-Asl, A.; Callaghan, S.; MacLaurin, J.G.; Winklhofer, K.F.; Rizzu, P.; Rippstein, P.; Kim, R.H.; Chen, C.X.; Fon, E.A.; Slack, R.S.; Harper, M.E.; McBride, H.M.; Mak, T.W.; Park, D.S. Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum. Mol. Genet. 19: 3734-3746.
184. Krebiehl, G.; Ruckerbauer, S.; Burbulla, L. F.; Kieper, N.; Maurer, B.; Waak, J.; Wolburg, H.; Gizatullina, Z.; Gellerich, F. N.; Woitalla, D.; Riess, O.; Kahle, P. J.; Proikas-Cezanne, T.; Kruger, R. Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS One 5:e9367; 2010.
185. Wang, X.; Petrie, T. G.; Liu, Y.; Liu, J.; Fujioka, H.; Zhu, X. Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J. Neurochem. 121: 830-839; 2011.
186. Thomas, K. J.; McCoy, M. K.; Blackinton, J.; Beilina, A.; van der Brug, M.; Sandebring, A.; Miller, D.; Maric, D.; Cedazo-Minguez, A.; Cookson, M. R. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum. Mol. Genet 20: 40-50; 2011.
187. Guo, L.; Wang, W.; Chen, S. G. Leucine-rich repeat kinase 2: relevance to Parkinson's disease. Int. J. Biochem. Cell Biol. 38: 1469-1475; 2006. (Pubitemid 43729302)
188. Devine, M. J.; Lewis, P. A. Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2. FEBS J. 275: 5748-5757; 2008.
189. Katchanov, J.; Harms, C.; Gertz, K.; Hauck, L.; Waeber, C.; Hirt, L.; Priller, J.; von Harsdorf, R.; Bruck, W.; Hortnagl, H.; Dirnagl, U.; Bhide, P. G.; Endres, M. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J. Neurosci. 21: 5045-5053; 2001. (Pubitemid 32622930)
190. Hodges, J. R.; Davies, R. R.; Xuereb, J. H.; Casey, B.; Broe, M.; Bak, T. H.; Kril, J. J.; Halliday, G. M. Clinicopathological correlates in frontotemporal dementia. Ann. Neurol. 56: 399-406; 2004. (Pubitemid 39166559)
191. West, A. B.; Moore, D. J.; Biskup, S.; Bugayenko, A.; Smith, W. W.; Ross, C. A.; Dawson, V. L.; Dawson, T. M. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. USA 102: 16842-16847; 2005. (Pubitemid 41688864)
192. Gloeckner, C. J.; Kinkl, N.; Schumacher, A.; Braun, R. J.; O'Neill, E.; Meitinger, T.; Kolch, W.; Prokisch, H.; Ueffing, M. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet 15: 223-232; 2006. (Pubitemid 43125977)
193. Biskup, S.; Moore, D. J.; Celsi, F.; Higashi, S.; West, A. B.; Andrabi, S. A.; Kurkinen, K.; Yu, S. W.; Savitt, J. M.; Waldvogel, H. J.; Faull, R. L.; Emson, P. C.; Torp, R.; Ottersen, O. P.; Dawson, T. M.; Dawson, V. L. Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann. Neurol. 60: 557-569; 2006. (Pubitemid 44871798)
194. Saha, S.; Guillily, M. D.; Ferree, A.; Lanceta, J.; Chan, D.; Ghosh, J.; Hsu, C. H.; Segal, L.; Raghavan, K.; Matsumoto, K.; Hisamoto, N.; Kuwahara, T.; Iwatsubo, T.; Moore, L.; Goldstein, L.; Cookson, M.; Wolozin, B. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J. Neurosci. 29: 9210-9218; 2009.
195. Zarranz, J. J.; Gomez-Esteban, J. C.; Atares, B.; Lezcano, E.; Forcadas, M. Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome. Mov. Disord 21: 107-111; 2006. (Pubitemid 43273762)
196. Hayashi, T.; Sakai, K.; Sasaki, C.; Zhang, W. R.; Abe, K. Phosphorylation of retinoblastoma protein in rat brain after transient middle cerebral artery occlusion. Neuropathol. Appl. Neurobiol. 26: 390-397; 2000. (Pubitemid 30609435)
197. Mendez, M. F. The neuropsychiatric aspects of boxing. Int. J. Psychiatry Med. 25: 249-262; 1995.
198. Gordon, N. Pantothenate kinase-associated neurodegeneration (Hallervor-den-Spatz syndrome). Eur. J. Paediatr. Neurol. 6: 243-247; 2002. (Pubitemid 36267296)
199. Wang, X.; Yan, M. H.; Fujioka, H.; Liu, J.; Wilson-Delfosse, A.; Chen, S. G.; Perry, G.; Casadesus, G.; Zhu, X. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum. Mol. Genet 21: 1931-1944; 2012.
200. Niu, J.; Yu, M.; Wang, C.; Xu, Z. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein. J. Neurochem. 122: 650-658; 2012.
201. Kamat, C. D.; Gadal, S.; Mhatre, M.; Williamson, K. S.; Pye, Q. N.; Hensley, K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J. Alzheimers Dis. 15: 473-493; 2008.
202. Yu, W.; Sun, Y.; Guo, S.; Lu, B.; Hum. Mol. Genet. 20(16): 3227-3240; 2011.